# Stage-Based Communication Rehabilitation in Amyotrophic Lateral Sclerosis (ALS): A Review of Strategies for Enhancing Quality of Life

**Authors:** Mark C. Jackson, Rafaelle B. Azarraga, Marcel P. Fraix, Devendra K. Agrawal

PMC · DOI: 10.26502/aimr.0230 · Archives of internal medicine research · 2026-01-31

## TL;DR

This review discusses communication rehabilitation strategies for ALS patients at different disease stages to improve their quality of life.

## Contribution

The paper introduces a stage-based approach to communication rehabilitation tailored to the progression of ALS.

## Key findings

- Proactive measures like voice banking are effective in early-stage ALS.
- Middle-stage interventions use alternative communication strategies based on patient ability.
- Late-stage interventions rely on advanced technology for locked-in patients.

## Abstract

Amyotrophic Lateral Sclerosis (ALS) is an incurable progressive degenerative neuromuscular disease. One way ALS affects patients is through dysarthria significantly impacting a patient’s quality of life by affecting their ability to communicate. This makes maintaining relationships, identity and autonomy difficult, all of which affect psychological wellbeing - a determinant of the quality of life. Dysarthria makes communication difficult, and because the regions affected by ALS first are different for each patient, creating strategies for rehabilitating communication can be challenging. In this review we explore the different communication rehabilitation options available and organize them based on if they are usable based on the onset of intelligibility and locked in state. Interventions before the onset of intelligibility in the early stage are proactive measures such as voice banking and education which empower patient autonomy and a sense of control. Interventions between onset of intelligibility and the locked-in state in the middle stage are alternative and augmentative communication strategies varied in accessibility and usability in patients based on their preferences and functional ability. Late-stage interventions which work after a patient with ALS has entered a locked-in state, are the most technologically advanced alternative and augmentative communication devices and rehabilitate function inaccessible by other methods in this disease stage. While assessing patient values and recommending interventions which meet patient needs is most important in rehabilitation of communication in patient with ALS, using a stage-based approach to evaluate and recommend the treatment of dysarthria and communication rehabilitation will optimize quality of life throughout the progression of disease.

## Linked entities

- **Diseases:** Amyotrophic Lateral Sclerosis (MONDO:0004976), ALS (MONDO:0004976)

## Full-text entities

- **Genes:** GLYAT (glycine-N-acyltransferase) [NCBI Gene 10249] {aka ACGNAT, GAT}
- **Diseases:** loss (MESH:D016388), cognitive impairment (MESH:D003072), death (MESH:D003643), Dysarthria (MESH:D004401), communication disability (MESH:D003147), spastic (MESH:D009128), glutamate (MESH:C537425), ALS (MESH:D000690), neurological diseases (MESH:D020271), hoarseness (MESH:D006685), Speech impairment (MESH:D013064), fatigue (MESH:D005221), pain (MESH:D010146), motor dysfunction (MESH:D000068079), eye gaze fatigue (MESH:D001248), degenerative neuromuscular disease (MESH:D009468), upper limb dysfunction (MESH:D038062), neurotoxic (MESH:D020258), flaccid (MESH:D009123), bulbar (MESH:D010244), Covid-19 (MESH:D000086382), oculomotor dysfunction (MESH:D015840), paralysis (MESH:D010243), Cortical hyperexcitability (MESH:D054220), eye gaze tiredness (MESH:D015835), Dependence on motor function (MESH:D019966), mitochondrial dysfunction (MESH:D028361), limb weakness (MESH:D018908), frontotemporal dementia (MESH:D057180), respiratory failure (MESH:D012131)
- **Chemicals:** ETCS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12857845/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12857845/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12857845/full.md

---
Source: https://tomesphere.com/paper/PMC12857845